tecfidera 240 mg capsule rigide gastroresistenti
biogen switzerland ag - dimethylis fumaras - capsule rigide gastroresistenti - dimethylis fumaras 240 mg, carmellosum natricum conexum, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, natrii laurilsulfas, triethylis citras, polysorbatum 80, talcum, simeticonum, kapselhülle: gelatina, e 171, e 172 (flavum), e 133, drucktinte: lacca, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 1.69 mg. - multiple sklerose - synthetika
plegridy 63 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 63 mcg/0,5 ml - peginterferonum beta-1a 63 µg l-arginini hydrochloridum, natrii acetas trihydricus, acido aceticum glaciale, polysorbatum 20, acqua iniectabilia q.s. per una soluzione invece di 0,5 ml. - multiple sklerose - biotechnologika
plegridy 94 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 94 mcg/0,5 ml - peginterferonum beta-1a 94 µg l-arginini hydrochloridum, natrii acetas trihydricus, acido aceticum glaciale, polysorbatum 20, acqua iniectabilia q.s. per una soluzione invece di 0,5 ml. - multiple sklerose - biotechnologika
plegridy 125 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 125 mcg/0,5 ml - peginterferonum beta-1a 125 µg l-arginini hydrochloridum, natrii acetas trihydricus, acido aceticum glaciale, polysorbatum 20, acqua iniectabilia q.s. per una soluzione invece di 0,5 ml. - multiple sklerose - biotechnologika
plegridy pen 63 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 63 mcg/0,5 ml - peginterferonum beta-1a 63 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika
plegridy pen 94 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 94 mcg/0,5 ml - peginterferonum beta-1a 94 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika
plegridy pen 125 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 125 mcg/0,5 ml - peginterferonum beta-1a 125 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika
spinraza 12mg/5ml soluzione per iniezione intrathekalen
biogen switzerland ag - nusinersenum - soluzione per iniezione intrathekalen - solvens: nusinersenum 12 mg ut nusinersenum natricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, kalii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. - trattamento della 5q associati ad atrofia muscolare spinale (sma) - synthetika
fampyra 10 mg retardtabletten
biogen switzerland ag - fampridinum - retardtabletten - fampridinum 10 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, titanii dioxidum, pro compresso obducto. - multiple sklerose - synthetika
dibaselab
abiogen pharma s.p.a. - colecalciferolo - colecalciferolo